Article Details
Retrieved on: 2024-02-01 16:09:59
Tags for this article:
Click the tags to see associated articles and topics
Summary
GT Biopharma's 1-for-30 reverse stock split aims to maintain its Nasdaq listing and meets the capital markets' minimum bid price requirement. The stock is tracked by TipRanks and will trade post-split on the stock market.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here